DoD Gulf War Illness, Clinical Consortium Award


Funding Opportunity ID: 293982
Opportunity Number: W81XWH-17-GWIRP-CCA
Opportunity Title: DoD Gulf War Illness, Clinical Consortium Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
CFDA Number(s): 12.420
Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:
Agency Code: DOD-AMRAA
Agency Name: Department of Defense
Dept. of the Army — USAMRAA
Posted Date: May 19, 2017
Close Date: Sep 21, 2017
Last Updated Date: May 19, 2017
Award Ceiling:
Award Floor:
Estimated Total Program Funding: $8,000,000
Expected Number of Awards: 1
Description: The GWIRP Clinical Consortium Award mechanism is being offered for the first time in FY17. The FY17 GWIRP Clinical Consortium Award is intended to support a major goal-/product-driven Consortium of exceptional institutions and investigators that will accelerate the clinical translation of basic GWI research into clinical therapies and ultimately decrease the impact of the illness. The objectives of the Consortium shall be to conceive, design, develop, and conduct collaborative Phase I and/or II clinical trials of promising therapeutic agents for the management or treatment of GWI.
Version: Synopsis 1

Source link


Please enter your comment!
Please enter your name here